Provided by Tiger Trade Technology Pte. Ltd.

Jazz Pharmaceuticals PLC

183.70
+3.081.71%
Volume:147.80K
Turnover:27.05M
Market Cap:11.31B
PE:-31.45
High:184.45
Open:182.00
Low:181.00
Close:180.62
52wk High:198.00
52wk Low:95.49
Shares:61.56M
Float Shares:58.65M
Volume Ratio:0.64
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8403
EPS(LYR):-5.8403
ROE:-8.47%
ROA:5.22%
PB:2.62
PE(LYR):-31.45

Loading ...

Jazz Pharmaceuticals EVP Robert Iannone Reports Sale of Common Shares

Reuters
·
Nov 20, 2025

Truist Adjusts Price Target on Jazz Pharmaceuticals Public to $220 From $205, Maintains Buy Rating

MT Newswires Live
·
Nov 19, 2025

Jazz Pharmaceuticals Plc : Truist Securities Raises Target Price to $220 From $205

THOMSON REUTERS
·
Nov 19, 2025

Jazz Pharmaceuticals to Join Citi's 2025 Global Healthcare Conference

Reuters
·
Nov 19, 2025

Truist ups Jazz Pharmaceuticals price target, says Ziihera is pipeline-in-a drug

TIPRANKS
·
Nov 19, 2025

U.S. RESEARCH ROUNDUP- Autodesk, Crowdstrike, Zscaler

Reuters
·
Nov 18, 2025

Jazz Pharmaceuticals Plc : RBC Raises Target Price to $194 From $155

THOMSON REUTERS
·
Nov 18, 2025

Jazz Pharmaceuticals Plc : Baird Raises Target Price to $209 From $160

THOMSON REUTERS
·
Nov 18, 2025

Jefferies Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
Nov 18, 2025

Top Midday Gainers

MT Newswires Live
·
Nov 18, 2025

Jazz Pharmaceuticals Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Nov 18, 2025

Top Midday Stories: Amazon to Sell Used Ford Vehicles on Website; Novo Nordisk Cuts Wegovy, Ozempic Prices

MT Newswires Live
·
Nov 18, 2025

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday

Benzinga
·
Nov 18, 2025

Jazz Pharmaceuticals price target raised to $205 from $185 at Morgan Stanley

TIPRANKS
·
Nov 17, 2025

Jazz Pharmaceuticals rises 20.8%

TIPRANKS
·
Nov 17, 2025

Sector Update: Health Care Stocks Mixed Pre-Bell Monday

MT Newswires Live
·
Nov 17, 2025

BUZZ-U.S. STOCKS ON THE MOVE- Alphabet, Quantum Computing, Jazz Pharma

Reuters
·
Nov 17, 2025

Zymeworks, Jazz Pharmaceuticals Shares Rise Following Positive Phase 3 Results for Cancer Treatment

Dow Jones
·
Nov 17, 2025

S&P 500 Futures Up In Premarket Trading; Jazz Pharmaceuticals, Clearwater Analytics Lead

Dow Jones
·
Nov 17, 2025

Jazz Pharmaceuticals Shares up 14.8% Premarket After Cancer Drug Meets Main Goal in Late-Stage Study

THOMSON REUTERS
·
Nov 17, 2025